SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-087870
Filing Date
2023-08-04
Accepted
2023-08-04 16:30:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tm2321790-1_s3.htm S-3 531169
2 EXHIBIT 1.2 tm2321790d2_ex1-2.htm EX-1.2 246325
3 EXHIBIT 5.1 tm2321790d2_ex5-1.htm EX-5.1 36318
4 EXHIBIT 5.2 tm2321790d2_ex5-2.htm EX-5.2 13722
5 EXHIBIT 23.1 tm2321790d2_ex23-1.htm EX-23.1 2211
6 EX-FILING FEES tm2321790d2_ex-filingfees.htm EX-FILING FEES 47039
7 GRAPHIC lg_nextcure-4c.jpg GRAPHIC 35347
8 GRAPHIC tm2321790d2_ex5-1img001.jpg GRAPHIC 1789
9 GRAPHIC tm2322851d1_ex5-2img001.jpg GRAPHIC 7818
  Complete submission text file 0001104659-23-087870.txt   940139
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273723 | Film No.: 231144446
SIC: 2834 Pharmaceutical Preparations